181 related articles for article (PubMed ID: 32546343)
21. Autoreactivity to hepatocellular antigens in primary biliary cirrhosis and primary sclerosing cholangitis.
Bedlow AJ; Donaldson PT; McFarlane BM; Lombard M; McFarlane IG; Williams R
J Clin Lab Immunol; 1989 Nov; 30(3):103-9. PubMed ID: 2642168
[TBL] [Abstract][Full Text] [Related]
22. Differential serum levels of eosinophilic eotaxins in primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis.
Landi A; Weismuller TJ; Lankisch TO; Santer DM; Tyrrell DL; Manns MP; Houghton M
J Interferon Cytokine Res; 2014 Mar; 34(3):204-14. PubMed ID: 24168449
[TBL] [Abstract][Full Text] [Related]
23. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
[TBL] [Abstract][Full Text] [Related]
24. Autoantibodies to glutathione S-transferase theta 1 in patients with primary sclerosing cholangitis and other autoimmune diseases.
Ardesjö B; Hansson CM; Bruder CE; Rorsman F; Betterle C; Dumanski JP; Kämpe O; Ekwall O
J Autoimmun; 2008 Jun; 30(4):273-82. PubMed ID: 18242955
[TBL] [Abstract][Full Text] [Related]
25. Patients with anti-Jo1 antibodies display a characteristic IgG Fc-glycan profile which is further enhanced in anti-Jo1 autoantibodies.
Fernandes-Cerqueira C; Renard N; Notarnicola A; Wigren E; Gräslund S; Zubarev RA; Lundberg IE; Lundström SL
Sci Rep; 2018 Dec; 8(1):17958. PubMed ID: 30560888
[TBL] [Abstract][Full Text] [Related]
26. [Autoimmune liver diseases. Part I].
Ziółkowski J; Zagozdzon R; Paczek L
Przegl Lek; 1999; 56(5):385-9. PubMed ID: 10554578
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic utility of IgG and IgM immunohistochemistry in autoimmune liver disease.
Moreira RK; Revetta F; Koehler E; Washington MK
World J Gastroenterol; 2010 Jan; 16(4):453-7. PubMed ID: 20101770
[TBL] [Abstract][Full Text] [Related]
28. [Autoantibodies in hepatology].
Johanet C; Dubel L; Chazouillères O
Pathol Biol (Paris); 1999 Nov; 47(9):997-1005. PubMed ID: 10609280
[TBL] [Abstract][Full Text] [Related]
29. Interpreting serological tests in diagnosing autoimmune liver diseases.
Invernizzi P; Lleo A; Podda M
Semin Liver Dis; 2007 May; 27(2):161-72. PubMed ID: 17520516
[TBL] [Abstract][Full Text] [Related]
30. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
Mattner J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
[TBL] [Abstract][Full Text] [Related]
31. [Clinical relevance of autoantibodies in chronic liver diseases].
Klein R; Berg PA
Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):567-72. PubMed ID: 7856262
[No Abstract] [Full Text] [Related]
32. Autoantibodies in Autoimmune Liver Disease-Clinical and Diagnostic Relevance.
Sebode M; Weiler-Normann C; Liwinski T; Schramm C
Front Immunol; 2018; 9():609. PubMed ID: 29636752
[TBL] [Abstract][Full Text] [Related]
33. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases.
Cabibi D; Tarantino G; Barbaria F; Campione M; Craxì A; Di Marco V
Dig Liver Dis; 2010 Aug; 42(8):585-92. PubMed ID: 20060371
[TBL] [Abstract][Full Text] [Related]
34. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
35. Primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune cholangitis.
Sherlock S
Clin Liver Dis; 2000 Feb; 4(1):97-113. PubMed ID: 11232193
[TBL] [Abstract][Full Text] [Related]
36. Autoimmune liver diseases and antiphospholipid antibodies positivity: a meta-analysis of literature studies.
Ambrosino P; Lupoli R; Spadarella G; Tarantino P; Di Minno A; Tarantino L; Di Minno MN
J Gastrointestin Liver Dis; 2015 Mar; 24(1):25-34, 3 p following 34. PubMed ID: 25822431
[TBL] [Abstract][Full Text] [Related]
37. Increased sensitivity of Treg cells from patients with PBC to low dose IL-12 drives their differentiation into IFN-γ secreting cells.
Liaskou E; Patel SR; Webb G; Bagkou Dimakou D; Akiror S; Krishna M; Mells G; Jones DE; Bowman SJ; Barone F; Fisher BA; Hirschfield GM
J Autoimmun; 2018 Nov; 94():143-155. PubMed ID: 30119881
[TBL] [Abstract][Full Text] [Related]
38. Histologically proven AMA positive primary biliary cholangitis but normal serum alkaline phosphatase: Is alkaline phosphatase truly a surrogate marker?
Sun C; Xiao X; Yan L; Sheng L; Wang Q; Jiang P; Lian M; Li Y; Wei Y; Zhang J; Chen Y; Li B; Li Y; Huang B; Li Y; Peng Y; Chen X; Fang J; Qiu D; Hua J; Tang R; Leung P; Gershwin ME; Miao Q; Ma X
J Autoimmun; 2019 May; 99():33-38. PubMed ID: 30709684
[TBL] [Abstract][Full Text] [Related]
39. IgG4-positive sclerosing cholangitis following autoimmune pancreatitis with deranged CA19.9.
Ong SL; Garcea G; Puls F; Richards C; Mulcahy K; Grant A; Dennison AR; Berry DP
Int J Surg Pathol; 2011 Feb; 19(1):84-7. PubMed ID: 18611930
[TBL] [Abstract][Full Text] [Related]
40. [Novel Insights of Primary Sclerosing Cholangitis and Primary Biliary Cholangitis].
Ahn DW
Korean J Gastroenterol; 2020 May; 75(5):246-256. PubMed ID: 32448856
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
